Acrivon Therapeutics, Inc. (ACRV)

CIK 1781174 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Acrivon Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 2, 202630000905148-26-004064
Sep 2, 202640000905148-26-004065
Aug 27, 202640000905148-26-003968
Aug 25, 20261440000905148-26-003924
Aug 20, 202640000905148-26-003838
Aug 20, 202640000905148-26-003839
Aug 20, 202640000905148-26-003840
Aug 20, 202640000905148-26-003836
Aug 20, 202640000905148-26-003837
Aug 13, 2026SCHEDULE 13G/A0001875620-26-000015
Aug 12, 2026S-80001193125-26-347003
Aug 12, 202610-Q0001193125-26-346819
Aug 12, 20268-K0001193125-26-346859
Aug 6, 202640000905148-26-003499
Jul 23, 202640000905148-26-003334
Jun 22, 202640000905148-26-003033
Jun 22, 202640001231919-26-000686
Jun 22, 202640000905148-26-003035
Jun 22, 202640000905148-26-003034
Jun 22, 202640000905148-26-003024
Jun 22, 202640000905148-26-003041
Jun 22, 202640000905148-26-003042
Jun 17, 20268-K0001193125-26-274410
May 26, 202640000905148-26-002652
May 22, 2026DEFA14A0001193125-26-236858